Herbal Therapy for Treatment of Recurrent Prostate Cancer
Completed · Phase 2
Conditions studied: Prostate Cancer
In brief
This study is about Prostate Health Cocktail, a combination supplement that contains vitamin D3, vitamin E, selenium, green tea extract, saw palmetto, lycopene, and soy derivatives. This product is currently available on the market, as herb and vitamin supplements are not regulated by the FDA. Each ingredient has been studied in prostate cancer cells and/or in patients with prostate cancer. At the doses included in this supplement, no serious side effects have been reported. The purpose of this study is to find out whether Prostate Health Cocktail can lower your PSA. Additionally, we will be looking to see whether taking this treatment causes any unexpected side effects, and whether certain blood tests can inform us about your disease status in addition to your PSA
Key facts
- Study ID
- NCT00669656
- Run by
- University of Southern California
- People needed
- 43
- Starts
- 2008-07-06
- Expected to finish
- 2014-10-14
- Last updated by the study team
- 2017-04-20
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may not qualify if…
- Atypical prostate carcinoma histology (ex: small cell, adenoid cystic)
- Evidence of bony or soft tissue metastatic disease on CT/MRI or bone scan or PET/CT
- Other invasive malignancy within prior 3 years, except for fully treated basal cell or squamous cell carcinoma of the skin.
- Full-dose anticoagulation therapy (warfarin or low molecular weight heparin) or antiplatelet therapy (clopidogrel or ticlopidine), with the exception of low-dose aspirin therapy (81 mg).
- Significant cardiac disease, included but not limited to angina, myocardial infarction, cardiomyopathy, congestive heart failure, and coronary artery disease which has required bypass surgery, angioplasty or stent placement.
- Significant uncontrolled comorbid condition which, in the opinion of the treating physician would compromise the subject's ability to comply with protocol requirements, or would pose undue risk for experiencing adverse events.
Where it is running
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.